Induced Physiological Ketosis in Asthenia and\or Decreased Tolerance to Physical and\or Mental Exertion
NCT ID: NCT05689697
Last Updated: 2023-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
88 participants
INTERVENTIONAL
2023-01-09
2023-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Effects of Exercise Combined With Ketone Ester Supplement
NCT06365957
Ketone Administration During Inactivity and Retraining
NCT05398042
Ketone Supplements and Substrate Oxidation and Physical Performance
NCT04737694
Exogenous Ketone Supplementation and Cognitive Function During Exercise
NCT04576026
Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19
NCT04573764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The duration of the study will be 15 days of treatment and 15 days of follow-up observation.
Patients will be assessed at screening/baseline, after 15 days and after 30 days.
The dose regimen: the shot of PanTrek, 25 ml, will be administered per os, twice per day, in the morning and in the evening, per se or deluted in 100 ml of water one hour before or after meal.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo group
Patients will recieve matched by taste and color shot of 25 ml liquid in ampules
PanTrek
administration of exogenouse keton body
Active treatment group
Patients will recieve shot of PanTrek 25 ml in anpules
PanTrek
administration of exogenouse keton body
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PanTrek
administration of exogenouse keton body
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of astenia and/or decreased tolerance to physical and\\or mental exertion
* ability of patients to understand assessment procedures
Exclusion Criteria
* participation in other trials
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ketonic Pharm LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Denis Burminskiy, MD, PhD
Role: STUDY_DIRECTOR
Mental health research center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratory of psychopharmacology Research center of mental health
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KetonicPharm
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.